{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:04:15Z","timestamp":1772759055439,"version":"3.50.1"},"reference-count":25,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"\n BACKGROUND:<\/jats:title>\n Few prospective studies have systematically evaluated the extent of recovery from incident acquired demyelinating syndromes (ADS) of the central nervous system in children.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n In a national cohort study of pediatric ADS, severity of the incident attack and extent of recovery by 12 months were evaluated. Annual evaluations were used to determine current diagnoses (monophasic ADS or multiple sclerosis [MS]) and new deficits.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n Of 283 children, 244 (86%) required hospitalization for a median (interquartile range [IQR]) of 6 (3\u201310) days, and 184 had moderate or severe deficits; 41 children were profoundly encephalopathic, 129 were unable to ambulate independently, and 59 with optic neuritis (ON) had moderately or severely impaired vision. Those with transverse myelitis (TM) and patients with monophasic disease were more likely to have moderate or severe deficits at onset. Twenty-seven children (10%) did not experience full neurologic recovery from their incident attack; 12 have severe residual deficits. Monophasic illness, TM, and moderate or severe deficits at onset were associated with poor recovery. After a median (IQR) follow-up of 5.06 (3.41\u20136.97) years, 59 children (21%) were diagnosed with MS; all recovered fully from their incident ADS attacks, although 6 subsequently acquired irreversible deficits after a median (IQR) observation period of 5.93 (4.01\u20137.02) years.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n ADS is a serious illness, with 86% of affected Canadian children requiring hospitalization. More than 90% of children recovered physically from their ADS event, including those children experiencing onset of MS. However, permanent visual or spinal cord impairment occurred in some children with ON or TM.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.2015-0028","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T13:51:21Z","timestamp":1433253081000},"page":"e115-e123","source":"Crossref","is-referenced-by-count":43,"title":["Recovery From Central Nervous System Acute Demyelination in Children"],"prefix":"10.1542","volume":"136","author":[{"given":"Julia","family":"O\u2019Mahony","sequence":"first","affiliation":[{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada;"},{"name":"The Hospital for Sick Children, Toronto, Ontario, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Winnipeg Health Sciences Center, University of Manitoba, Winnipeg, Manitoba, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Laporte","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Ann","family":"Yeh","sequence":"additional","affiliation":[{"name":"Division of Neurology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Bar-Or","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Montreal Neurologic Institute and Hospital, McGill University, Montreal, Quebec, Canada;"},{"name":"Experimental Therapeutics Program, Montreal Neurologic Institute and Hospital, McGill University, Montreal, Quebec, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Phan","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children, Toronto, Ontario, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Buckley","sequence":"additional","affiliation":[{"name":"Janeway Children\u2019s Health and Rehabilitation Centre, St John\u2019s, Newfoundland, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Callen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Connolly","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Pohl","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Emmanuelle","family":"Dilenge","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Montreal Children\u2019s Hospital, Montreal, Quebec, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Bernard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Montreal Children\u2019s Hospital, Montreal, Quebec, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Lortie","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Universit\u00e9 de Montreal, Montreal, Quebec, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Lowry","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Athen","family":"MacDonald","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Queen\u2019s University, Kingston, Ontario, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Meek","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saint John Regional Hospital, Saint John, New Brunswick, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"S\u00e9bire","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Montreal Children\u2019s Hospital, Montreal, Quebec, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Venkateswaran","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Wood","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, IWK Health Centre, Halifax, Nova Scotia, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Yager","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stollery Children\u2019s Hospital, Edmonton, Alberta, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Banwell","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children, Toronto, Ontario, Canada;"},{"name":"The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2015,7,1]]},"reference":[{"issue":"10","key":"2021120820322186300_B1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler"},{"issue":"5","key":"2021120820322186300_B2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1474-4422(11)70045-X","article-title":"Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.","volume":"10","author":"Banwell","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1","key":"2021120820322186300_B3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1352458512445944","article-title":"Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.","volume":"19","author":"Absoud","year":"2013","journal-title":"Mult Scler"},{"issue":"2","key":"2021120820322186300_B4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpeds.2003.10.056","article-title":"First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.","volume":"144","author":"Mikaeloff","year":"2004","journal-title":"J Pediatr"},{"issue":"5","key":"2021120820322186300_B5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00431-006-0249-2","article-title":"Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: results of a nationwide survey.","volume":"166","author":"Pohl","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2021120820322186300_B6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0883073812443006","article-title":"Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program.","volume":"28","author":"O\u2019Mahony","year":"2013","journal-title":"J Child Neurol"},{"issue":"10","key":"2021120820322186300_B7","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica.","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"2021120820322186300_B8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria.\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"issue":"11","key":"2021120820322186300_B9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"25","key":"2021120820322186300_B10","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa067597","article-title":"Natural history of multiple sclerosis with childhood onset.","volume":"356","author":"Renoux","year":"2007","journal-title":"N Engl J Med"},{"key":"2021120820322186300_B11"},{"issue":"3","key":"2021120820322186300_B12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ene.12327","article-title":"Clinical presentation of pediatric multiple sclerosis before puberty.","volume":"21","author":"Huppke","year":"2014","journal-title":"Eur J Neurol"},{"issue":"2","key":"2021120820322186300_B13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.wnl.0000224757.69746.fb","article-title":"The clinical features, MRI findings, and outcome of optic neuritis in children","volume":"67","author":"Wilejto","year":"2006","journal-title":"Neurology"},{"key":"2021120820322186300_B14"},{"issue":"1","key":"2021120820322186300_B15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0883073811420495","article-title":"The demographic, clinical, and magnetic transverse myelitis in children","volume":"27","author":"Thomas","year":"2012","journal-title":"J Child Neurol"},{"issue":"4","key":"2021120820322186300_B16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.0000000000001179","article-title":"Acute idiopathic transverse myelitis in children: early predictors of relapse and disability.","volume":"84","author":"Deiva","year":"2015","journal-title":"Neurology"},{"issue":"18","key":"2021120820322186300_B17","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1212\/01.wnl.0000260609.11357.6f","article-title":"Acute transverse myelitis in childhood: center-based analysis of 47 cases.","volume":"68","author":"Pidcock","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"2021120820322186300_B18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1352458511430704","article-title":"Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis.","volume":"18","author":"Chitnis","year":"2012","journal-title":"Mult Scler"},{"issue":"10","key":"2021120820322186300_B19","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1177\/1352458510375568","article-title":"The management of multiple sclerosis in children: a European view.","volume":"16","author":"Ghezzi","year":"2010","journal-title":"Mult Scler"},{"issue":"3","key":"2021120820322186300_B20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/01.wnl.0000339482.84392.bd","article-title":"Incidence of acquired demyelination of the CNS in Canadian children.","volume":"72","author":"Banwell","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"2021120820322186300_B21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/0883073812465010","article-title":"Cognitive trajectories in 4 patients with pediatric-onset multiple sclerosis: serial evaluation over a decade.","volume":"28","author":"Marin","year":"2013","journal-title":"J Child Neurol"},{"issue":"13","key":"2021120820322186300_B22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/WNL.0b013e3181f4d821","article-title":"Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up.","volume":"75","author":"Amato","year":"2010","journal-title":"Neurology"},{"issue":"8","key":"2021120820322186300_B23","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1212\/01.WNL.0000158474.24191.BC","article-title":"Cognitive functioning in children and adolescents with multiple sclerosis.","volume":"64","author":"MacAllister","year":"2005","journal-title":"Neurology"},{"issue":"20","key":"2021120820322186300_B24","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1212\/01.wnl.0000312276.23177.fa","article-title":"Cognitive and psychosocial features of childhood and juvenile MS.","volume":"70","author":"Amato","year":"2008","journal-title":"Neurology"},{"key":"2021120820322186300_B25"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/1\/e115\/1095069\/peds_2015-0028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/136\/1\/e115\/1095069\/peds_2015-0028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:34:56Z","timestamp":1639010096000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/136\/1\/e115\/28843\/Recovery-From-Central-Nervous-System-Acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,7,1]]},"published-print":{"date-parts":[[2015,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2015-0028","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,1]]}}}